throbber
Case 1:16-cv-01221-LPS Document 52 Filed 05/23/18 Page 1 of 5 PageID #: 382
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`Plaintiffs,
`
`Defendants.
`
`
`
`
`
`
`C.A. No. 16-1221 (LPS)
`CONSOLIDATED
`
`BAYER HEALTHCARE LLC and BAYER
`HEALTHCARE PHARMACEUTICALS
`INC.,
`
`
`
`
`
`TEVA PHARMACEUTICALS USA, INC.,
`et al.,
`
`
`
`
`
`
`
`
`
`
`
`v.
`
`
`
`
`
`JOINT CLAIM CONSTRUCTION CHART
`
`In accordance with Paragraph 11 of the Scheduling Order, Plaintiffs Bayer HealthCare
`
`LLC and Bayer HealthCare Pharmaceuticals Inc. (collectively, “Bayer” ), and Defendants Teva
`
`Pharmaceuticals USA, Inc. (“Teva”), Apotex Inc. and Apotex Corp. (“Apotex”) respectfully
`
`submit this Joint Claim Construction Chart.
`
`Attached as Exhibit A is a table identifying the parties’ proposed claim construction
`
`positions with respect to certain terms in the asserted claims of U.S. Patent Nos. 8,680,124 and
`
`9,458,107. No claim term contained in any of the asserted claims of U.S. Patent No. 7,351,834
`
`or 8,637,553 is proposed for construction.
`
`
`
`

`

`Case 1:16-cv-01221-LPS Document 52 Filed 05/23/18 Page 2 of 5 PageID #: 383
`
`
`
`
`
`
`
`
`
`SHAW KELLER LLP
`
`/s/ Karen E. Keller
`
`
`
`
`John W. Shaw (#3362)
`Karen E. Keller (#4489)
`David M. Fry (#5486)
`1105 North Market Street
`12th Floor
`Wilmington, DE 19801
`(302) 298-0701
`jshaw@shawkeller.com
`kkeller@shawkeller.com
`dfry@shawkeller.com
`
`Attorneys for Defendant Teva Pharmaceuticals
`USA, Inc.
`
`MORRIS JAMES LLP
`
`/s/ Kenneth L. Dorsney
`
`
`
`
`Kenneth L. Dorsney (#3726)
`500 Delaware Avenue, Suite 1500
`Wilmington, DE 19801-1494
`(302) 888-6855
`kdorsney@morrisjames.com
`
`Attorneys for Defendants Apotex Inc. and
`Apotex Corp.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`MORRIS, NICHOLS, ARSHT & TUNNELL LLP
`
`/s/ Derek J. Fahnestock
`
`
`
`
`Jack B. Blumenfeld (#1014)
`Derek J. Fahnestock (#4705)
`Anthony D. Raucci (#5948)
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`(302) 658-9200
`jblumenfeld@mnat.com
`dfahnestock@mnat.com
`araucci@mnat.com
`
`Attorneys for Plaintiffs Bayer HealthCare LLC
`and Bayer HealthCare Pharmaceuticals Inc.
`
`
`
`May 23, 2018
`
`
`2
`
`

`

`Case 1:16-cv-01221-LPS Document 52 Filed 05/23/18 Page 3 of 5 PageID #: 384
`
`
`
`
`
`Claim Term/Phrase
`
`All asserted claims
`Preambles
`
`
`Claims 1, 2, 4, 29
`“acquired resistance”
`
`
`
`Claim Term/Phrase
`
`
`Claims 1, 29-31
`“an effective amount”
`
`Exhibit A
`
`Proposed Constructions for U.S. Patent No. 8,680,124 (’124 patent)1:
`
`Proposed Construction Agreed to By Bayer and Teva
`
`The preambles are limiting.
`
`
`resistant and/or substantially less responsive to the effects of the drug compared to initial
`responsiveness
`
`
`Bayer’s Proposed Construction and
`Supporting Intrinsic Evidence
`
`an amount which is effective to treat any
`symptom or aspect of the cancer or the tumor
`
`Intrinsic Evidence
`
`’124 Patent:
` col. 6, ll. 4-24
` claims 1, 29-31
`
`
`’124 Patent File History:
` originally filed specification and claims
`
`Teva’s Proposed Construction and
`Supporting Intrinsic Evidence
`
`an amount that is effective to combat, alleviate,
`reduce, relieve, or improve one or more of the
`symptoms associated with a cancer, including
`but not limited to amounts that cause tumor
`regression, cell death, apoptosis, necrosis;
`inhibit cell proliferation; tumor growth, tumor
`metastasis, tumor migration, tumor invasion;
`reduce disease progression; stabilize the
`disease; reduce or inhibit angiogenesis;
`prolong patient survival; enhance quality of
`life; and/or reduce the frequency, severity,
`intensity, and/ or duration of any adverse
`
`
`1 This patent is not at issue in the cases against Apotex Inc. and Apotex Corp., C.A. No. 16-1222 and C.A. No. 17-334.
`
`
`
`

`

`Case 1:16-cv-01221-LPS Document 52 Filed 05/23/18 Page 4 of 5 PageID #: 385
`
`
`
`symptoms or activities.
`
`Intrinsic Evidence
`
`’124 Patent:
` col. 6, ll. 4-24
` claims 3 and 28
`
`
`
` a
`
`
`
` subject that is resistant and/or substantially
`less responsive to the effects of imatinib
`compared to that subject’s initial
`responsiveness to imatinib
`
`Intrinsic Evidence
`
`’124 Patent:
` Title
` Abstract
` col. 1, l. 64 – col. 2, l. 4
` col. 2, ll. 12-46
` col. 3, ll. 3-14
` col. 3, ll. 42-44
` col. 4, ll. 36-50
` col. 6, ll. 41-55
` col. 7, ll. 1-4
` col. 18, ll. 36-41
`
` a
`
` subject who has been treated with imatinib (no
`construction necessary)
`
`Intrinsic Evidence
`
`’124 Patent:
` col. 1, l. 67 – col. 2, l. 4
` col. 4, ll. 51-54
` col. 6, ll. 25-27
` claims 1, 2, 4, 26-27, 29-31
`
`
`’124 Patent File History:
` originally filed specification and claims
`
`
`
`
`Claims 30, 31
`“a subject who has been
`treated with imatinib”
`
`
`
`
`
`
`
`2
`
`

`

`Case 1:16-cv-01221-LPS Document 52 Filed 05/23/18 Page 5 of 5 PageID #: 386
`
`Proposed Constructions for U.S. Patent No. 9,458,107 (’107 patent):
`
`Proposed Construction Agreed to By All Parties
`
` pharmaceutical composition
`
` A
`
`
`in an amount from 0.0001% to a maximum of 0.05%
`
`3
`
`
`
`
`Claim Term/Phrase
`
`Claims 3, 4, 12, 13, 14, 18, 20
`“A composition”
`
`
`Claims 1-4
`“in an amount equal to or less
`than 0.05%”
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket